Vitro Biopharma, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Vitro Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Vitro Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending July 31, 2024 was -$149K, a 82.9% increase year-over-year.
  • Vitro Biopharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending July 31, 2024 was -$9.76M, a 65.1% decline year-over-year.
  • Vitro Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$5.4M, a 21.3% increase from 2022.
  • Vitro Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$6.86M.
  • Vitro Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2015 was -$246K, a 0.27% increase from 2014.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$5.4M +$1.46M +21.3% Nov 1, 2022 Oct 31, 2023 10-Q 2024-09-16
2022 -$6.86M Nov 1, 2021 Oct 31, 2022 10-K 2024-01-29
2015 -$246K +$662 +0.27% Nov 1, 2014 Oct 31, 2015 10-K 2016-09-22
2014 -$247K $0 0% Nov 1, 2013 Oct 31, 2014 10-K 2016-09-22
2013 -$247K -$18.9K -8.29% Nov 1, 2012 Oct 31, 2013 10-Q 2016-01-22
2012 -$228K -$214K -1524% Nov 1, 2011 Oct 31, 2012 10-K 2014-02-12
2011 -$14K +$243K +94.5% Nov 1, 2010 Oct 31, 2011 10-K 2013-02-12
2010 -$257K Nov 1, 2009 Oct 31, 2010 10-K/A 2012-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.